| Reference |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ebru Doneray, Kemal Utku Yazici, Ipek Percinel Yazici, Bilal Ustunda. Altered Arginine/Nitric Oxide Pathway in Children Diagnosed Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol 20 issue 2 2022 35466106 |
in this study, we investigated the levels of arginine, nitric oxide (no), asymmetric dimethylarginine (adma), and adrenomedullin that are presumed to play a role in attention deficit hyperactivity disorder (adhd) etiology, and to compare the findings with healthy controls. |
2022-04-25 |
2022-04-26 |
Not clear |
| Mingyue Zhao, Xin Liu, Yuzhu Hou, Tongtong Yang, Jiaquan Xu, Rui S. Combination of Electrochemistry and Mass Spectrometry to Study Nitric Oxide Metabolism and Its Modulation by Compound K in Breast Cancer Cells. Analytical chemistry vol issue 2022 35306816 |
the levels of l-arginine and asymmetric dimethylarginine (adma) and the amount of the nitric oxide (no) production have recently been linked to breast cancer and pharmaceutical effect evaluation. |
2022-03-21 |
2022-04-14 |
Not clear |
| Juliane Hannemann, Julia Zummack, Jonas Hillig, Leonard Rendant-Gantzberg, Rainer B\\xc3\\xb6ge. Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood. Journal of clinical medicine vol 11 issue 4 2022 35207213 |
asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthesis and a cardiovascular risk factor. |
2022-02-25 |
2022-02-27 |
Not clear |
| Eslam E Elhawary, Seham F Khedr, Hala M Nagy, Mohamed H El-Bradey, Mohamed R Elshanshor. Correlation of Asymmetric Dimethyl Arginine Level to Sickle Retinopathy in Children With Sickle Cell Disease. Journal of pediatric hematology/oncology vol issue 2022 35180766 |
asymmetric dimethyl arginine (adma) is a competitive inhibitor of nitric oxide synthetase especially in l-arginine deficiency, which is the case in sickle cell disease (scd). |
2022-02-18 |
2022-02-23 |
Not clear |
| Marius Marc-Daniel Mader, Patrick Czorlic. The role of L-arginine metabolism in neurocritical care patients. Neural regeneration research vol 17 issue 7 2021 34916417 |
asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase and can lead to endothelial dysfunction. |
2022-02-04 |
2022-01-13 |
Not clear |
| Angelo Zinellu, Arduino A Mangon. An updated systematic review and meta-analysis of the effect of statins on asymmetric dimethylarginine. Nitric oxide : biology and chemistry vol issue 2022 35032642 |
we conducted an updated systematic review and meta-analysis of the effect of statins on serum or plasma concentrations of the endogenous inhibitor of endothelial nitric oxide synthase, asymmetric n |
2022-02-01 |
2022-01-27 |
Not clear |
| Angelo Zinellu, Arduino A Mangon. An updated systematic review and meta-analysis of the effect of statins on asymmetric dimethylarginine. Nitric oxide : biology and chemistry vol issue 2022 35032642 |
we conducted an updated systematic review and meta-analysis of the effect of statins on serum or plasma concentrations of the endogenous inhibitor of endothelial nitric oxide synthase, asymmetric n |
2022-01-15 |
2022-01-27 |
Not clear |
| Juliane Hannemann, Patricia Siques, Lena Schmidt-Hutten, Julia Zummack, Julio Brito, Rainer B\\xc3\\xb6ge. Association of Genes of the NO Pathway with Altitude Disease and Hypoxic Pulmonary Hypertension. Journal of clinical medicine vol 10 issue 24 2021 34945057 |
chronic intermittent hypoxia leads to high-altitude pulmonary hypertension, which is associated with high asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthesis. |
2021-12-24 |
2022-01-13 |
Not clear |
| Marius Marc-Daniel Mader, Patrick Czorlic. The role of L-arginine metabolism in neurocritical care patients. Neural regeneration research vol 17 issue 7 2021 34916417 |
asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase and can lead to endothelial dysfunction. |
2021-12-17 |
2022-01-13 |
Not clear |
| Vijay Raj, Suganya Natarajan, Marimuthu C, Suvro Chatterjee, Mohankumar Ramasamy, Ganesh Munuswamy Ramanujam, Mariadhas Valan Arasu, Naif Abdullah Al-Dhabi, Ki Choon Choi, Jesu Arockiaraj, Kanchana Karuppia. Cholecalciferol and metformin protect against lipopolysaccharide-induced endothelial dysfunction and senescence by modulating sirtuin-1 and protein arginine methyltransferase-1. European journal of pharmacology vol 912 issue 2021 34710370 |
we found that lps challenge (i) increased arginine methylation through up-regulated protein arginine methyltransferase-1 (prmt1) mrna, intracellular concentrations of asymmetric dimethylarginine (adma) and homocysteine (hcy); (ii) up-regulated cell senescence through mitigated sirtuin-1 (sirt1) mrna, nicotinamide adenine dinucleotide (nad+) concentration, telomerase activity and total antioxidant capacity; and (iii) lead to endothelial dysfunction through compromised nitric oxide (nox) production. |
2021-11-22 |
2022-01-13 |
Not clear |
| Pratishtha Chatterjee, Yeo-Jin Cheong, Atul Bhatnagar, Kathryn Goozee, Yunqi Wu, Matthew McKay, Ian J Martins, Wei L F Lim, Steve Pedrini, Michelle Tegg, Victor L Villemagne, Prita R Asih, Preeti Dave, Tejal M Shah, Cintia B Dias, Stephanie J Fuller, Heidi Hillebrandt, Sunil Gupta, Eugene Hone, Kevin Taddei, Henrik Zetterberg, Kaj Blennow, Hamid R Sohrabi, Ralph N Martin. Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults. Journal of neurochemistry vol 159 issue 2 2021 32679614 |
metabolites belonging to biogenic amine (creatinine, symmetric dimethylarginine, asymmetric dimethylarginine; adma, kynurenine, trans-4-hydroxyproline), amino acid (citrulline, proline, arginine, asparagine, phenylalanine, threonine) and acylcarnitine classes were observed to have positive correlations with plasma nf-l, suggesting a link between neurodegeneration and biological pathways associated with neurotransmitter regulation, nitric oxide homoeostasis, inflammation and mitochondrial function. |
2021-11-19 |
2022-01-13 |
Not clear |
| Jung-Hoon Pyun, Byeong-Yun Ahn, Tuan Anh Vuong, Su Woo Kim, Yunju Jo, Jaehyung Jeon, Seung Ho Baek, Jaewon Kim, Sungsu Park, Gyu-Un Bae, Jun-Hyuk Choi, Jae-Ryong Kim, Dongryeol Ryu, Sang-Jin Lee, Jong-Sun Kan. Inducible Prmt1 ablation in adult vascular smooth muscle leads to contractile dysfunction and aortic dissection. Experimental & molecular medicine vol 53 issue 10 2021 34635781 |
protein arginine methyltransferase 1 (prmt1) is a major enzyme catalyzing asymmetric arginine dimethylation of proteins that are sources of asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthase. |
2021-11-18 |
2022-01-13 |
Not clear |
| Neveen Tawfik Abed, Omima Mohamed Abdel Haie, Amira Ibrahim Mansour, Eman Rateb Abd Almonae. Relation of asymmetric dimethylarginine with pulmonary morbidities in neonatal respiratory distress syndrome. Journal of neonatal-perinatal medicine vol 14 issue 4 2021 33646184 |
asymmetric dimethyl arginine (adma) is an endogenous inhibitor of nitric oxide synthase (nos) is important in different diseases characterized by decreased nitric oxide (no) availability. |
2021-11-15 |
2022-01-13 |
Not clear |
| Inderjit Singh, Judong Kim, Nishant Saxena, Seungho Choi, S M Touhidul Islam, Avtar K Singh, Mushfiquddin Khan, Jeseong Wo. Vascular and immunopathological role of Asymmetric Dimethylarginine (ADMA) in Experimental Autoimmune Encephalomyelitis. Immunology vol 164 issue 3 2021 34310708 |
asymmetric dimethylarginine (adma) is an endogenous nitric oxide synthase (nos) inhibitor/uncoupler inducing vascular pathology. |
2021-11-12 |
2022-01-13 |
Not clear |
| Guo-Hua Ni, Jin-Fang Cheng, Yuan-Jian Li, Qi-Ying Xie, Tian-Lun Yang, Mei-Fang Che. Effect of profilin-1 on the asymmetric dimethylarginine-induced vascular lesion-associated hypertension. The Kaohsiung journal of medical sciences vol issue 2021 34741409 |
previous studies have demonstrated that the levels of asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide (no) synthesis, are strongly associated with hypertension, diabetes, and cardiovascular diseases. |
2021-11-06 |
2022-01-13 |
Not clear |
| Ibrahim Musa Yola, Carlee Moser, Meredith S Duncan, Edzard Schwedhelm, Dorothee Atzler, Renke Maas, Juliane Hannemann, Rainer H B\\xc3\\xb6ger, Ramachandran S Vasan, Vanessa Xanthaki. Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study. PloS one vol 16 issue 9 2021 34492019 |
circulating levels of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (adma), are positively associated with the prevalence of metabolic syndrome (mets) in cross-sectional investigations. |
2021-11-05 |
2022-01-13 |
Not clear |
| Paulina Guerrero-Almaraz, Manuel Quiroz, Joseph H Reibenspies, Marcetta Y Darensbour. Linear and Bent Nitric Oxide Ligand Binding in an Asymmetric Butterfly Complex: Inorganic chemistry vol 60 issue 21 2021 34157221 |
linear and bent nitric oxide ligand binding in an asymmetric butterfly complex: two synthetic approaches to install metallodithiolate ligands on molybdenum centers using the synthons [mo |
2021-11-02 |
2022-01-13 |
Not clear |
| Chien-Ning Hsu, You-Lin Tai. Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond. Children (Basel, Switzerland) vol 8 issue 10 2021 34682102 |
asymmetric dimethylarginine (adma), an endogenous nitric oxide (no) synthase inhibitor, inhibits no synthesis and contributes to the pathogenesis of many human diseases. |
2021-10-26 |
2022-01-13 |
Not clear |
| Fady Azmy Kyrillos, Mohamad Motawea, Mohamed Abd-El-Aziz, Azza Al-Bayoumy, Talal Amer, Mamdouh El-Naha. Plasma levels of Asymmetric Di Methyl Arginine and endothelial dysfunction in diabetic subjects with neuropathic foot ulcer. Foot (Edinburgh, Scotland) vol 48 issue 2021 34388426 |
asymmetric dimethyl arginine (adma) is an amino acid that acts as an endogenous competitive inhibitor of nitric oxide synthase, leading to endothelial dysfunction (ed). |
2021-10-25 |
2022-01-13 |
Not clear |
| Irakli Kopaliani, Natalia Jarzebska, Silke Billoff, Anne Kolouschek, Jens Martens-Lobenhoffer, Stefan R Bornstein, Stefanie M Bode-B\\xc3\\xb6ger, Vinitha N Ragavan, Norbert Weiss, Arduino A Mangoni, Andreas Deussen, Roman N Rodiono. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling. American journal of physiology. Heart and circulatory physiology vol 321 issue 5 2021 34533401 |
cardiovascular complications are the leading cause of death, and elevated levels of asymmetric dimethyarginine (adma), an endogenous inhibitor of nitric oxide synthase, are implicated in their pathophysiology. |
2021-10-25 |
2022-01-14 |
Not clear |